Effect of Renin-Angiotensin System Blockade on Calcium Channel Blocker-Associated Peripheral Edema  Harikrishna Makani, MD, Sripal Bangalore, MD, MHA,

Slides:



Advertisements
Similar presentations
Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Effect of renin-angiotensin system blockade on calcium.
Advertisements

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.
Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 
Effect of Renin-Angiotensin System Blockade on Calcium Channel Blocker-Associated Peripheral Edema  Harikrishna Makani, MD, Sripal Bangalore, MD, MHA,
Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials  Sripal Bangalore, MD, MHA, Bora Toklu,
Salt, Tomato Soup, and the Hypocrisy of the American Heart Association
Isolated Systolic Hypertension: An Update After SPRINT
Sexuality The American Journal of Medicine
2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?  Sripal Bangalore, MD,
An Unusual Cause of Leg Ulcerations
Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  Chirag Bavishi, MD, MPH,
Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review  Shelley R. Salpeter, MD, Jacob S.
Richard V. Milani, MD, Carl J. Lavie, MD, Robert M
The Great “Infiltrator”: An Uncommon Cause of Hepatitis
Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease  Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,
Samy Suissa, PhD, Abbas Kezouh, PhD, Pierre Ernst, MD, MSc 
Frederic Rahbari-Oskoui, MD, MS  American Journal of Kidney Diseases 
Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure
Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials  Kenneth R. McQuaid, MD, Loren.
Changes in Lipid Profile of Obese Patients Following Contemporary Bariatric Surgery: A Meta-Analysis  Sean P. Heffron, MD, MS, MSc, Amar Parikh, MD, Alexandar.
All in His Head: An Unexpected Space-occupying Lesion
Sayed H. Naderi, BMedSci, Jonathan P. Bestwick, MSc, David S. Wald, MD 
Overview of Current Learning Theories for Medical Educators
Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks  Sripal Bangalore, MD, MHA, Gbenga Ogedegbe,
Franz H. Messerli, MD, Sripal Bangalore, MD, MHA 
Epidemiology of Myelodysplastic Syndromes
On the Palms of His Hands: ACTH-Induced Hyperpigmentation
Robert Goulden, MBBS, MSc, MPhil, MA  The American Journal of Medicine 
Misconceptions and Facts About Hypertrophic Cardiomyopathy
Age and Gender Differences in Quality of Care and Outcomes for Patients with ST- segment Elevation Myocardial Infarction  Sripal Bangalore, MD, MHA, Gregg.
Methylene Chloride Intoxication Treated With Hyperbaric Oxygen Therapy
The Reply The American Journal of Medicine
Hong-Tao Tie, MD, Rui Shi, MD  The American Journal of Medicine 
Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials  Sripal Bangalore, MD, MHA, Bora Toklu,
Gun Ownership and Firearm-related Deaths
Occam's Razor and the Diagnosis of Mantle Cell Lymphoma
Natasha Chhabra, MD, Steve Lee, MD, Elias G. Sakalis, MD 
Gout in African Americans
Clinical Outcomes with β-Blockers for Myocardial Infarction: A Meta-analysis of Randomized Trials  Sripal Bangalore, MD, MHA, Harikrishna Makani, MD,
Hereditary Angioedema: New Findings Concerning Symptoms, Affected Organs, and Course  Konrad Bork, MD, Gabriele Meng, MD, Petra Staubach, MD, Jochen Hardt,
Acute Kidney Injury and Death Associated With Renin Angiotensin System Blockade in Cardiothoracic Surgery: A Meta-analysis of Observational Studies  Rabi.
Repeated Hemoglobin A1C Ordering in the VA Health System
Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016  Murray Epstein, MD, Daniel A. Duprez,
Volume 94, Issue 3, Pages (September 2018)
Polyunsaturated Fatty Acids and Kidney Disease
Does Methylphenidate Reduce the Symptoms of Chronic Fatigue Syndrome?
Clinical Outcomes After Treatment of Cocaine-Induced Chest Pain with Beta-Blockers: A Systematic Review and Meta-Analysis  Kevin Bryan Lo, MD, Hafeez.
Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study  Walid Saliba, MD, MPH, Naomi.
Jennifer Tjia, MD, MSCE, Jeroan Allison, MD, Jane S
Prevalence and Risk Factors for Erectile Dysfunction in the US
Insomnia in the Elderly: Cause, Approach, and Treatment
Cluster Syncope The American Journal of Medicine
Statin Use and Risk of COPD Exacerbation Requiring Hospitalization
To Reduce Stroke with PFO Closure, Respect the Shunt
Ali Ahmed, MD, MPH, Michael W. Rich, MD, Michael Zile, MD, Paul W
When Guidelines Need Guidance…
One-way Versus Two-way Text Messaging on Improving Medication Adherence: Meta- analysis of Randomized Trials  David S. Wald, MD, FRCP, Shahena Butt, MSc,
Bilateral Proptosis as Initial Manifestation of Mantle Cell Lymphoma
A Post-cure Complication
Isolated Systolic Hypertension: An Update After SPRINT
Misconceptions and Facts about Pericardial Effusion and Tamponade
Sister Mary Joseph's Node
Plasma Lactescence in Acute Pancreatitis
Volume 73, Issue 5, Pages (March 2008)
Direct Observation of Residents: A Model for an Assessment System
Falls in Older Adults: Risk Assessment, Management and Prevention
Toward a More Responsible News Media
David Tian, MD, Ram Jhingan Mohan, MD, Gary Stallings, MD 
Hypophosphatemia: Diagnostic Significance in Legionnaires’ Disease
Presentation transcript:

Effect of Renin-Angiotensin System Blockade on Calcium Channel Blocker-Associated Peripheral Edema  Harikrishna Makani, MD, Sripal Bangalore, MD, MHA, Jorge Romero, MD, Omar Wever-Pinzon, MD, Franz H. Messerli, MD  The American Journal of Medicine  Volume 124, Issue 2, Pages 128-135 (February 2011) DOI: 10.1016/j.amjmed.2010.08.007 Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 Selection of studies. ACE=ACE inhibitor; ARB=ARB; CCB=calcium channel blocker; RAS=renin-angiotensin system. The American Journal of Medicine 2011 124, 128-135DOI: (10.1016/j.amjmed.2010.08.007) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 Head-to-head comparison of calcium channel blocker with calcium channel blocker/renin-angiotensin-receptor blocker combination on the incidence of peripheral edema. ACEI = ACE inhibitor; CCB = calcium channel blocker; CI = confidence interval; RAS = renin-angiotensin system. The American Journal of Medicine 2011 124, 128-135DOI: (10.1016/j.amjmed.2010.08.007) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 3 Pooled incidence of peripheral edema and withdrawal due to edema with calcium channel blocker and calcium channel blocker/renin-angiotensin-receptor blocker combination. *P < .05 comparing calcium channel blocker with calcium channel blocker/renin-angiotensin-receptor combination. CCB = calcium channel blocker; RAS = renin-angiotensin system. The American Journal of Medicine 2011 124, 128-135DOI: (10.1016/j.amjmed.2010.08.007) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 4 Head-to-head comparison of calcium channel blocker with calcium channel blocker/renin-angiotensin-receptor blocker combination on the withdrawal due to peripheral edema. ACEI = ACE inhibitor; CCB = calcium channel blocker; CI = confidence interval; RAS = renin-angiotensin system. The American Journal of Medicine 2011 124, 128-135DOI: (10.1016/j.amjmed.2010.08.007) Copyright © 2011 Elsevier Inc. Terms and Conditions